What are Sympathomimetic drugs?

Sympathomimetic drugs are pharmacologic agents that share a common mechanism (typically targeting Alpha-1 adrenergic receptor). 0 are currently marketed, with 2 more in clinical development.

Sympathomimetic

0 marketed 1 in Phase 3 1 in Phase 2

This page covers all Sympathomimetic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Alpha-1 adrenergic receptor, Adrenaline receptor.

Targets

Alpha-1 adrenergic receptor · Adrenaline receptor

Phase 3 pipeline (1)

noradrenaline and vascular filling · Centre Hospitalier Universitaire, Amiens · Cardiovascular
Noradrenaline increases vascular tone and cardiac contractility by stimulating alpha-1 adrenergic receptors.

Phase 2 pipeline (1)

Adrenaline nasal pack · Shaheed Mohtarma Benazir Bhutto Institue of Trauma · Emergency Medicine
Adrenaline nasal pack works by releasing adrenaline into the nasal passages to rapidly increase blood pressure and improve breathing in cases of anaphylaxis or severe allergic reactions.